Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

Cyp2c65 Inhibitors

Cyp2c65 inhibitors are a class of chemical compounds that specifically target and inhibit the activity of the Cyp2c65 enzyme, a member of the cytochrome P450 superfamily. The Cyp2c65 enzyme is involved in the oxidative metabolism of a broad range of substrates, including endogenous compounds such as hormones, fatty acids, and signaling molecules, as well as exogenous substances like drugs and environmental chemicals. The enzyme functions by catalyzing the monooxygenation of its substrates, a process that introduces an oxygen atom into the substrate molecule. This oxidative modification typically increases the solubility of the substrate, facilitating its further metabolism, conjugation, or excretion. Cyp2c65 plays a crucial role in the detoxification processes and the regulation of various metabolic pathways, particularly in organs like the liver where cytochrome P450 enzymes are predominantly expressed.

Inhibitors of Cyp2c65 are typically designed as small molecules that bind to the active site of the enzyme, preventing it from catalyzing the oxidation of its natural substrates. These inhibitors may function by occupying the enzyme's substrate-binding pocket, thereby blocking the access of substrates to the catalytic site, or by inducing conformational changes that reduce the enzyme's catalytic efficiency. The design and development of Cyp2c65 inhibitors involve detailed structural analysis of the enzyme to identify critical regions involved in substrate recognition and enzymatic activity. By inhibiting Cyp2c65, researchers can gain insights into the specific role of this enzyme in various metabolic processes and understand how its inhibition impacts the broader network of cytochrome P450-mediated reactions. The study of Cyp2c65 inhibitors is crucial for elucidating the enzyme's substrate specificity, its interaction with other metabolic enzymes, and its overall contribution to maintaining metabolic balance and detoxification within the body. This research enhances our understanding of the functional diversity of cytochrome P450 enzymes and underscores their importance in the biotransformation and clearance of both endogenous and exogenous compounds in biological systems.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Fluconazole

86386-73-4sc-205698
sc-205698A
500 mg
1 g
$54.00
$84.00
14
(1)

Antifungal agent acting as a direct inhibitor of CYP2C65 by interfering with xenobiotic metabolic processes. Modifies intracellular membrane functions, hindering the enzyme's predicted activity.

Cimetidine

51481-61-9sc-202996
sc-202996A
5 g
10 g
$62.00
$86.00
1
(1)

H2 receptor antagonist indirectly inhibiting CYP2C65 by modulating xenobiotic metabolic processes. Disrupts cytoplasmic and intracellular membrane functions, influencing the enzyme's predicted activity.

Enoxacin

74011-58-8sc-205670
sc-205670A
500 mg
1 g
$40.00
$49.00
2
(2)

Fluoroquinolone antibiotic acting as a direct inhibitor of CYP2C65 by affecting monooxygenase activity. Modifies endoplasmic reticulum dynamics, hindering the enzyme's participation in this pathway.

Phenylbutazone

50-33-9sc-204843
5 g
$32.00
1
(0)

Nonsteroidal anti-inflammatory drug directly inhibiting CYP2C65 by suppressing monooxygenase activity. Alters intracellular membrane dynamics, impacting the enzyme's predicted activity in xenobiotic metabolism.

Econazole

27220-47-9sc-279013
5 g
$240.00
(0)

Antifungal agent acting as a direct inhibitor of CYP2C65 by interfering with xenobiotic metabolic processes. Modifies membrane-bounded organelle functions, hindering the enzyme's predicted location.

Disulfiram

97-77-8sc-205654
sc-205654A
50 g
100 g
$53.00
$89.00
7
(1)

Alcohol deterrent indirectly inhibiting CYP2C65 by impacting caffeine oxidase activity. Disrupts intracellular membrane-bounded organelle functions, influencing the enzyme's predicted activity.

(±)-Sulfinpyrazone

57-96-5sc-202822
sc-202822A
1 g
5 g
$42.00
$94.00
2
(1)

Uricosuric agent indirectly inhibiting CYP2C65 by modulating xenobiotic metabolic processes. Alters cytoplasmic and intracellular membrane dynamics, affecting the enzyme's predicted activity.

Fluoxetine

54910-89-3sc-279166
500 mg
$318.00
9
(1)

Selective serotonin reuptake inhibitor indirectly impacting CYP2C65 by suppressing monooxygenase activity. Influences intracellular membrane-bounded organelle functions, hindering the enzyme's activity.

Ticlopidine Hydrochloride

53885-35-1sc-205861
sc-205861A
1 g
5 g
$32.00
$99.00
2
(1)

Antiplatelet agent acting as a direct inhibitor of CYP2C65 by interfering with xenobiotic metabolic processes. Alters membrane-bounded organelle dynamics, hindering the enzyme's participation.

Trimethoprim

738-70-5sc-203302
sc-203302A
sc-203302B
sc-203302C
sc-203302D
5 g
25 g
250 g
1 kg
5 kg
$67.00
$161.00
$255.00
$721.00
$3401.00
4
(1)

Antibiotic acting as a direct inhibitor of CYP2C65 by affecting monooxygenase activity. Modifies endoplasmic reticulum dynamics, hindering the enzyme's participation in xenobiotic metabolism.